A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

April 30, 2027

Conditions
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsPancreatic NeoplasmColorectal Neoplasms
Interventions
DRUG

LY4170156

Intravenous

DRUG

Bevacizumab

IV

DRUG

carboplatin

IV

Trial Locations (24)

4101

RECRUITING

Icon Cancer Centre South Brisbane, QLD

5000

RECRUITING

Cancer Research SA, Adelaide, SA

10016

RECRUITING

New York University (NYU) Clinical Cancer Center, New York

10065

RECRUITING

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

10408

RECRUITING

National Cancer Center, Goyang-si Gyeonggi-do

11501

RECRUITING

NYU Langone Health - Long Island, Mineola

20089

RECRUITING

Istituto Clinico Humanitas, Rozzano

20141

RECRUITING

Istituto Europeo di Oncologia, Milan

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

31059

RECRUITING

Oncopole Claudius Regaud, Toulouse

43210

RECRUITING

The Ohio State University (OSU) Wexner Medical Center, Columbus

44805

RECRUITING

Institut de Cancerologie de l'Ouest - site St-Herblain, Saint-Herblain

46010

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

49546

RECRUITING

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

69008

RECRUITING

Centre Leon Berard, Lyon

84119

RECRUITING

START Mountain Region, West Valley City

85258

RECRUITING

HonorHealth, Scottsdale

92037

RECRUITING

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

02215

NOT_YET_RECRUITING

Dana-Farber Cancer Institute, Boston

77030-4000

RECRUITING

The University of Texas - MD Anderson Cancer Center, Houston

411-8777

RECRUITING

Shizuoka Cancer Center, Shizuoka

104-0045

RECRUITING

National Cancer Center Hospital, Tokyo

135-8550

RECRUITING

Cancer Institute Hospital of JFCR, Tokyo

08035

RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY